Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. - Wikidata - awgldk - TriplyDB

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

http://www.wikidata.org/entity/Q34168543

about

What is new for an old molecule? Systematic review and recommendations on the use of resveratrol Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence Challenges in Analyzing the Biological Effects of Resveratrol Resveratrol and Ophthalmic Diseases Understanding the molecular mechanisms of cancer prevention by dietary phytochemicals: From experimental models to clinical trials Role of Natural Stilbenes in the Prevention of Cancer New concepts and challenges in the clinical translation of cancer preventive therapies: the role of pharmacodynamic biomarkers Resveratrol: A potential challenger against gastric cancer Role of phytochemicals in colorectal cancer prevention Polyphenol Stilbenes: Molecular Mechanisms of Defence against Oxidative Stress and Aging-Related Diseases Natural compounds as anticancer agents: Experimental evidence Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models Cancer therapy with phytochemicals: evidence from clinical studies Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases Diabetic complications in pregnancy: is resveratrol a solution?Resveratrol and cancer: Challenges for clinical translation Mitochondrial oxidative stress in aging and healthspan Therapeutic targeting of replicative immortality Research progress on chemopreventive effects of phytochemicals on colorectal cancer and their mechanisms Anticancer Efficacy of Polyphenols and Their Combinations Resveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent manner Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/β-catenin signaling pathway Growth-Inhibiting Activity of Resveratrol Imine Analogs on Tumor Cells In Vitro Pharmacological Intervention through Dietary Nutraceuticals in Gastrointestinal Neoplasia.Resveratrol and cancer: focus on in vivo evidence.Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention.The Repeated Administration of Resveratrol Has Measurable Effects on Circulating T-Cell Subsets in Humans.Improving In Vivo Efficacy of Bioactive Molecules: An Overview of Potentially Antitumor Phytochemicals and Currently Available Lipid-Based Delivery Systems.Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders.Trials and tribulations of interrogating biomarkers to define efficacy of cancer risk reductive interventions Brewers' rice induces apoptosis in azoxymethane-induced colon carcinogenesis in rats via suppression of cell proliferation and the Wnt signaling pathway Epigenetic changes induced by curcumin and other natural compounds.Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis Resveratrol: review on therapeutic potential and recent advances in drug delivery.Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells.Inhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFRβ, PI3K/Akt and MAPK pathways.Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage.Resveratrol in combination with other dietary polyphenols concomitantly enhances antiproliferation and UGT1A1 induction in Caco-2 cells.Resveratrol attenuates diabetic nephropathy via modulating angiogenesis.

P2860

Q21089966-80D441AD-26FF-4040-B7A2-EACB88D096BE Q24616554-0A8E28E8-0B21-4570-9B05-A9ADED30725B Q24618313-B22D39A2-2448-4A63-97C2-437D3EB23FC9 Q26746257-0BC3E34C-C715-4FBE-A4C8-D43CA72B20DA Q26750615-17B3685B-81D0-4327-A8D3-7367621F1EBD Q26765196-2E780588-D2F5-4384-BA41-8F3834A117A5 Q26769976-357C7603-ABE0-4A79-9C41-CB3116099214 Q26774577-0691E27C-2CB3-42D3-8F66-56B4EED4EA59 Q26784390-AE54552B-D96B-4BD7-9D1E-EB8AA14EDF7C Q26797253-4D5C4095-2C5A-4FFF-90D7-7D11784A7621 Q26800956-90122AEC-FC75-49D9-B67E-5AFC5E2E2C64 Q26823107-FA3E6462-C6A9-4C4A-AA25-648841602A6E Q26824390-C39C2CA7-3E6C-451A-9B12-684FABF90AD3 Q26827407-7422734A-CEEF-4C79-A4F2-7EEA38E35991 Q27002456-237AA7B3-4D3F-4E4B-9158-8D516C7F1838 Q27012844-848B0355-5112-4CDD-9A35-F7402818E7FD Q27015712-E058DB01-AA5E-461A-93E1-B94922939322 Q27025099-3FF14C75-D8A3-4D44-A952-5DB195A34203 Q27027457-512A9D78-B6F8-4CE4-98D4-1038FCA0020D Q28067369-F4F2DC55-046D-4016-BF70-EF6ABAAB7370 Q28076137-1085AC7D-A841-4127-B062-709DD0FEA2BB Q28535352-490CA25C-1951-45E7-8199-3120B7E5FCB9 Q28541242-823D5323-5AC7-40DC-922D-F6B134C0A0FE Q28818518-840748DA-77A0-4FED-B2FD-B7DA2FC593AF Q30252185-0DF1B626-EB1D-4C44-83AF-A875F0885446 Q33578943-D772E281-8AB7-409E-9390-1EF4F953F727 Q33661094-9E2DB76F-A54E-4D58-8FA9-FC68B15A58E4 Q33701615-1943BF12-1CCF-4808-AEC3-D5AEE8189443 Q33710442-4C748393-E276-4A95-B24C-E44ED3D7AC38 Q33827813-022D91A1-8E1D-4B83-96B9-BC0B3B756DB7 Q34072742-79717E11-E1B7-4185-9B21-19B54D206BFD Q34100186-884B88E9-0D8E-4601-AEE6-D3F2E9C7C528 Q34180255-8BD2CECB-65A0-4454-86F9-DCD146F42F85 Q34316229-96E3DDA4-22EF-47A7-B9A4-5841A5D2E2F2 Q34420121-9F06A1DA-435F-4DC2-A283-58410FDA0DD5 Q34518736-420D32FF-7352-442B-BE9C-5B2E3C82A69C Q34607101-205CB7B0-031B-407A-B3B0-F68C426F7B91 Q34638026-B37EE4F2-48C5-4B7A-874F-BDD817D7F084 Q35013544-BF0FD206-16C6-486F-98E6-33122122633B Q35061522-4D3AAEC2-9E1B-48F0-A028-74961DD5BBAA

P2860

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

http://www.wikidata.org/entity/Q34168543

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

@ast

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

@en

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

@nl

type

label

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

@ast

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

@en

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

@nl

prefLabel

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

@ast

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

@en

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

@nl

P1433

Q34168543-6C603001-C6B0-416A-833F-F4E5B8EC8C4A

P1476

Q34168543-26ABDCE8-E0DC-4F4E-A04E-EDE5A2BDA7EB

P2093

Q34168543-0CF4A38B-215B-40C3-AA92-5DD850CC54BE

Q34168543-239BEBED-CF02-463B-8A62-820596A0C5DA

Q34168543-290F1338-6133-40D4-99EF-31D592D02B2C

Q34168543-432433AD-0E7C-4674-9735-A54D57C6E7B0

Q34168543-69FA2E98-D2CB-4236-844A-2DB5E0809D0E

Q34168543-77BDA34E-FB46-4D5F-AFF6-F99A6F06424D

Q34168543-805CB131-565D-438C-987F-720F2BA20E9F

Q34168543-9169AF8A-CB5A-43A9-B491-8DE56EF5F744

Q34168543-A4D44FA2-A141-45AC-BEEC-57D4350856BF

Q34168543-AA87840D-990D-4759-B15B-CF2FA7EF61EA

P2860

Q34168543-1144201F-79B0-4114-A212-ABBC218AE62E

Q34168543-12E33674-8DD6-48C3-9C35-06CE724A5D8C

Q34168543-143346C4-5824-4951-89F0-6362556318E4

Q34168543-23C1E467-7343-421B-BD61-AC3AA815FCEC

Q34168543-256BF6C2-93FE-437F-83F6-A8D2663B4D5D

Q34168543-2A857651-D4F5-459A-A813-42A54B6D97B4

Q34168543-3F0AE352-3CF2-4FE5-8516-2585203BE690

Q34168543-43AF5B12-769B-4EE0-B926-9FDCB73F149F

Q34168543-4FB3A265-90D7-4D86-B896-A05CBC22F717

Q34168543-5EC035B6-3803-4084-A318-9662121C2A5A

P304

Q34168543-9BE9CDF7-7F0C-41D8-B9E2-534282F99496

P31

Q34168543-96B5E426-F5BF-455B-96F2-2B370433864D

P356

Q34168543-4CD63889-643B-4CCD-A0C2-C39818CBE9B0

P407

Q34168543-BD194A33-1D88-48AB-A994-21F615965235

P433

Q34168543-90BF6787-F37B-4165-991C-8DE70F067251

P478

Q34168543-26C80D78-EB65-41A3-85E0-F5FF2A528573

P50

Q34168543-79B5637D-7EFA-420D-96E5-BD7ABE44B64A

P577

Q34168543-AB21A8D2-1E98-411B-ACED-4108A78DB80D

P698

Q34168543-3C02FD88-3687-40E4-A73B-58C62185C093

P921

Q34168543-2AE570F8-E428-411A-B7D6-5E04B9EA6C4B

Q34168543-D2CC81FE-1689-4FDF-AF9E-461A123E063A

Q34168543-E2B7E806-138D-45C8-BF75-DBD1B6941ED9

P932

Q34168543-12C6C50E-D391-43C1-B2E2-ED238FD0A788

P356

0008-5472.CAN-10-2027

P1433

Cancer Research

P1476

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients

@en

P2093

Andreas J Gescher

http://www.w3.org/2001/XMLSchema#string

Andrew S Miller

http://www.w3.org/2001/XMLSchema#string

David Hemingway

http://www.w3.org/2001/XMLSchema#string

Dean E Brenner

http://www.w3.org/2001/XMLSchema#string

James A Crowell

http://www.w3.org/2001/XMLSchema#string

Karen Brown

http://www.w3.org/2001/XMLSchema#string

Ketan R Patel

http://www.w3.org/2001/XMLSchema#string

Kevin P West

http://www.w3.org/2001/XMLSchema#string

Marjorie Perloff

http://www.w3.org/2001/XMLSchema#string

Robert G Britton

http://www.w3.org/2001/XMLSchema#string

P2860

Resveratrol: a review of preclinical studies for human cancer prevention

The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force

Stool water content and colonic drug absorption: contrasting effects of lactulose and codeine

Therapeutic potential of resveratrol: the in vivo evidence

Resveratrol suppresses colitis and colon cancer associated with colitis.

Absorption of three wine-related polyphenols in three different matrices by healthy subjects.

High absorption but very low bioavailability of oral resveratrol in humans.

Bioavailability of trans-resveratrol from red wine in humans.

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent.

Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography

P304

7392-7399

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-10-2027

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

Donald J L Jones

P577

2010-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20841478

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

2948608

http://www.w3.org/2001/XMLSchema#string